The global nuclear medicine market is projected to grow significantly, reaching $14.1 billion by 2028 with a compound annual growth rate (CAGR) of 12.3%. This growth is driven by factors such as personalized medicine, advancements in oncology and neurology research, sustainable practices, and the rise of telemedicine services. Key trends anticipated in the coming years include the development of radioimmunotherapy, hybrid imaging technologies, and the integration of artificial intelligence in nuclear medicine. Increasing incidences of cardiovascular diseases and cancer are also propelling demand for nuclear medicine as these conditions necessitate advanced diagnostic and therapeutic solutions. The report highlights major players in the market, including GE Healthcare and Lantheus Medical Imaging, and outlines the market's segmentation by type, application, and end-user.
Mon, 09 Sep 2024 08:20:57 GMT | WhaTech